Synthesis and Biological Evaluation of Coumarin Derivatives as Inhibitors of Mycobacterium bovis (BCG). - RIIP - Réseau International des Instituts Pasteur Accéder directement au contenu
Article Dans Une Revue Chemical Biology and Drug Design Année : 2012

Synthesis and Biological Evaluation of Coumarin Derivatives as Inhibitors of Mycobacterium bovis (BCG).

Résumé

The coumarin compounds are an important class of biologically active molecules, which have attractive caught the attention of many organic and medicinal chemists, due to potential pharmaceutical implications and industrial applications. We herein report the one-pot procedure for the efficient synthesis of coumarin derivatives using commercially available substrates via isocyanide-based multicomponent condensation reactions. These compounds were evaluated for anti-mycobacterium activity against Mycobacterium bovis (Bacillus Calmette-Guerin). The preliminary results indicated that all of the tested compounds showed relatively good activity against the test organism. The compounds 7e, 7l, and 7m showed high anti-tuberculosis activity.

Domaines

Pharmacologie
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée
Loading...

Dates et versions

pasteur-00753191 , version 1 (18-11-2012)

Identifiants

Citer

Ali Hossein Rezayan, Parisa Azerang, Soroush Sardari, Afshin Sarvary. Synthesis and Biological Evaluation of Coumarin Derivatives as Inhibitors of Mycobacterium bovis (BCG).. Chemical Biology and Drug Design, 2012, 80 (6), pp.929-36. ⟨10.1111/cbdd.12044⟩. ⟨pasteur-00753191⟩

Collections

RIIP RIIP_IRAN
42 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More